PAPER Beach TG, Potter PE, Kuo YM, Emmerling MR, Durham RA, Webster SD, Walker DG, Sue LI, Scott S, Layne KJ, Roher AE

Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta deposition.

Neurosci Lett. 2000 Mar 31;283(1):9-12. PubMed.

PAPER Fankhauser F, Ricka J, Rol P, Kwasniewska S, Niederer P

[Protein-condensation diseases--molecular basis of cataract formation].

Klin Monbl Augenheilkd. 2000 Feb;216(2):75-8. PubMed.

PAPER Thulborn KR, Martin C, Voyvodic JT

Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers.

AJNR Am J Neuroradiol. 2000 Mar;21(3):524-31. PubMed.

PAPER Van Hoesen GW, Parvizi J, Chu CC

Orbitofrontal cortex pathology in Alzheimer's disease.

Cereb Cortex. 2000 Mar;10(3):243-51. PubMed.

PAPER Shikiar R, Shakespeare A, Sagnier PP, Wilkinson D, McKeith I, Dartigues JF, Dubois B

The impact of metrifonate therapy on caregivers of patients with Alzheimer's disease: results from the MALT clinical trial. Metrifonate in Alzheimer's Disease Trial.

J Am Geriatr Soc. 2000 Mar;48(3):268-74. PubMed.

PAPER Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR

Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study.

Am J Clin Nutr. 2000 Apr;71(4):993-8. PubMed.

PAPER Rampa A, Bisi A, Belluti F, Gobbi S, Valenti P, Andrisano V, Cavrini V, Cavalli A, Recanatini M

Acetylcholinesterase inhibitors for potential use in Alzheimer's disease: molecular modeling, synthesis and kinetic evaluation of 11H-indeno-[1,2-b]-quinolin-10-ylamine derivatives.

Bioorg Med Chem. 2000 Mar;8(3):497-506. PubMed.

PAPER Hösli E, Hösli L

Colocalization of neurotransmitter receptors on astrocytes in explant cultures of rat CNS.

Neurochem Int. 2000 Apr;36(4-5):301-11. PubMed.

PAPER Dahl C, Haug LS, Spilsberg B, Johansen J, Ostvold AC, Diemer NH

Reduced [3H]IP3 binding but unchanged IP3 receptor levels in the rat hippocampus CA1 region following transient global ischemia and tolerance induction.

Neurochem Int. 2000 Apr;36(4-5):379-88. PubMed.

PAPER Robinson SR

Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes.

Neurochem Int. 2000 Apr;36(4-5):471-82. PubMed.

PAPER Andreani A, Leoni A, Locatelli A, Morigi R, Rambaldi M, Pietra C, Villetti G

4-Aminopyridine derivatives with antiamnesic activity.

Eur J Med Chem. 2000 Jan;35(1):77-82. PubMed.

PAPER Golbraikh A, Bernard P, Chrétien JR

Validation of protein-based alignment in 3D quantitative structure-activity relationships with CoMFA models.

Eur J Med Chem. 2000 Jan;35(1):123-36. PubMed.

PAPER Näslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

JAMA. 2000 Mar 22-29;283(12):1571-7. PubMed.

PAPER Selkoe DJ

The origins of Alzheimer disease: a is for amyloid.

JAMA. 2000 Mar 22-29;283(12):1615-7. PubMed.

PAPER Di Iorio A, Zito M, Lupinetti M, Abate G

Are vascular factors involved in Alzheimer's disease? Facts and theories.

Aging (Milano). 1999 Dec;11(6):345-52. PubMed.